American CryoStem Corporation

CRYO · OTC
Analyze with AI
9/30/2021
9/30/2020
9/30/2019
9/30/2018
Operating Activities
Net Income-$2,880-$1,179-$1,082-$1,491
Dep. & Amort.$69$35$32$27
Deferred Tax$0$0$0$0
Stock-Based Comp.$1,161$418$0$0
Change in WC$756-$416$274$553
Other Non-Cash$590$628$279$736
Operating Cash Flow-$304-$515-$497-$174
Investing Activities
PP&E Inv.-$91-$13-$50-$225
Net Acquisitions$0$0$0-$300
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$91-$13-$50-$525
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$143$401$280$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$362$545$502$357
Financing Cash Flow$362$545$502$357
Forex Effect$0$0$0$0
Net Chg. in Cash-$34$18-$45-$342
Supplemental Information
Beg. Cash$42$24$68$410
End Cash$8$42$24$68
Free Cash Flow-$395-$527-$547-$399
American CryoStem Corporation (CRYO) Financial Statements & Key Stats | AlphaPilot